Position in CRSP
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$50,449
+$6,447 QoQ
Shares Held
925
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#358
of 519 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Darwin Wealth Management, LLC holds $3,593,117 across 9 Biotechnology names. CRSP ranks #3 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DYN |
Dyne Therapeutics, Inc.
|
155,270 | $3,448,546 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
500 | $93,640 | |
| 3 | CRSP |
CRISPR Therapeutics AG
This page
|
925 | $50,449 | |
| 4 | NVAX |
Novavax Inc
|
25 | $235 | |
| 5 | ABEO |
Abeona Therapeutics Inc.
|
26 | $160 | |
| 6 | ENLV |
Enlivex Ltd.
|
10 | $82 | |
| 7 | XBIO |
Xenetic Biosciences, Inc.
|
2 | $5 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
0 | $0 |
All Filings in CRSP
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,449 | 925 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $44,002 | 925 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $48,507 | 925 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $59,949 | 925 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $22,520 | 463 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,755 | 463 | Shares | Sole | 2025-08-18 | |
| 2024-12-31 | $18,223 | 463 | Shares | Sole | 2025-09-02 | |
| 2024-09-30 | $43,456 | 925 | Shares | Sole | 2024-11-08 | |
| 2020-03-31 | $18,024 | 425 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||